Compare DexCom, Inc. (DXCM) vs Kaltura Inc (KLTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Kaltura Inc — how do they compare? DexCom, Inc. trades at $84.38 (market cap $31.86B), while Kaltura Inc trades at $1.32 (market cap $199.08M). The key difference: DexCom, Inc. is far larger — about 160× Kaltura Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, Kaltura Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Kaltura Inc for 21 Days on average.
| DXCM | KLTR | |
|---|---|---|
Market Cap | $31.86B | $199.08M |
Volume | 3,607,070 | 175,927 |
Sector | Health | Technology |
52-Week High | $92.34 | $1.89 |
52-Week Low | $54.84 | $1.08 |
Typical Hold Time | 62 Days | 21 Days |
Enterprise Value | $31.32B | $211.29M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $84.3, up 1.09% today, with a bearish technical signal but strong fundamentals. Revenue grew to $4.66B in 2025, with net income of $836.3M and a 17.93% margin. The stock has a P/E of 33.32 and P/S of 6.74. Recent news highlights growth in CGM adoption for Type 2 diabetes. Analyst consensus is bullish with an average price target of $95.07, supported by 42 buy ratings.
Outlook remains positive due to earnings beats and market expansion, but risks include competition and reimbursement challenges. The stock offers growth potential, yet investors should monitor execution against high valuations and technical resistance near $85.
KLTR trades at $1.33, up 3.91% today, showing positive momentum despite a bearish technical signal. The company demonstrates improving fundamentals with revenue stabilizing around $181M and net losses narrowing from -$68M in 2022 to -$12M in 2025. Recent earnings beats and industry recognition for AI-powered video platforms provide optimism, though negative ROE (-134.25%) and high debt levels remain concerns.
KLTR presents a turnaround story with improving financials and strong AI positioning, but faces significant execution risks. The stock offers speculative upside if the company can achieve profitability, though current valuation metrics (P/S 1.08, EV/EBITDA 271.59) reflect market skepticism about near-term earnings potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Kaltura Inc
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments: (i) Enterprise, Education, and Technology (EE&T)
Read more on KLTR →
